Table 4.
Analysis of cancer-associated VTE stratified by race and primary site, n= 186
| Incidence of VTE per Cancer Type | |||||
|---|---|---|---|---|---|
|
|
|||||
| Primary site | Whites | Blacks | p-value | Others✝ | p-value |
| Lung (%) | 13/1212 (1.07) | 17/566 (3.0) | 0.006 | 3/142 (2.1) | 0.231* |
| Gastric/Small Intestine (%) | 0/235 (0) | 6/211 (2.84) | 0.011* | 2/59 (3.39) | 0.039* |
| Colon and Rectum (%) | 6/667 (0.9) | 14/512 (2.73) | 0.028 | 2/126 (1.59) | 0.750* |
| Breast (%) | 4/1021 (0.39) | 10/918 (1.1) | 0.123 | 3/320 (0.94) | 0.368* |
Abbreviations: VTE, venous thromboembolism.
p-value obtained using Fisher’s exact test.
Note: p-values compare incidence of VTE in Blacks and Others versus Whites.
including, but not limited to patients of Spanish origin.